Cite

HARVARD Citation

    Roberts, S. et al. (2021). A short report on NGM282/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH). Expert opinion on therapeutic targets. pp. 889-895. [Online]. 
  
Back to record